Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Fenoglio-Preiser

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The American Journal of Surgical Pathology|June 17, 2005
Intestinal spirochetosisEdward R Uhlemann, Cecilia Fenoglio-Preiser
Pathology|January 31, 2003
Gastric carcinoma distal to the cardia: a review of the epidemiological pathology of the precusors to a preventable cancerGrant N Stemmermann, Cecilia Fenoglio-Preiser
Clinical & Experimental Metastasis|July 10, 2008
Acetylcholinesterase supports anchorage independence in colon cancerMoyeenuddin Syed, Cecilia Fenoglio-Preiser, Kenneth A Skau, et al.
American Journal of Clinical Pathology|September 30, 2005
Serrated polyps of the large intestine: a morphologic and molecular review of an evolving conceptDale C Snover, Jeremy R Jass, Cecilia Fenoglio-Preiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Stability of phosphoprotein as a biological marker of tumor signalingAmanda F Baker, Tomislav Dragovich, Nathan T Ihle, et al.
Annals of Surgical Oncology|April 8, 2003
Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinomaAndrew M Lowy, Cecilia Fenoglio-Preiser, On Ja Kim, et al.
Cancer Research|June 18, 2002
beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancerWilson M Clements, Jiang Wang, Amod Sarnaik, et al.
Cancer Research|May 3, 2006
beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancerAndrew M Lowy, Wilson M Clements, John Bishop, et al.
Cancer Research|July 10, 2007
The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progressionRyan M Thomas, Kenya Toney, Cecilia Fenoglio-Preiser, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The American Journal of Surgical Pathology|June 17, 2005
Intestinal spirochetosisEdward R Uhlemann, Cecilia Fenoglio-Preiser
Pathology|January 31, 2003
Gastric carcinoma distal to the cardia: a review of the epidemiological pathology of the precusors to a preventable cancerGrant N Stemmermann, Cecilia Fenoglio-Preiser
Clinical & Experimental Metastasis|July 10, 2008
Acetylcholinesterase supports anchorage independence in colon cancerMoyeenuddin Syed, Cecilia Fenoglio-Preiser, Kenneth A Skau, et al.
American Journal of Clinical Pathology|September 30, 2005
Serrated polyps of the large intestine: a morphologic and molecular review of an evolving conceptDale C Snover, Jeremy R Jass, Cecilia Fenoglio-Preiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Stability of phosphoprotein as a biological marker of tumor signalingAmanda F Baker, Tomislav Dragovich, Nathan T Ihle, et al.
Annals of Surgical Oncology|April 8, 2003
Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinomaAndrew M Lowy, Cecilia Fenoglio-Preiser, On Ja Kim, et al.
Cancer Research|June 18, 2002
beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancerWilson M Clements, Jiang Wang, Amod Sarnaik, et al.
Cancer Research|May 3, 2006
beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancerAndrew M Lowy, Wilson M Clements, John Bishop, et al.
Cancer Research|July 10, 2007
The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progressionRyan M Thomas, Kenya Toney, Cecilia Fenoglio-Preiser, et al.
Pageof 1